← Leaderboards
Joseph Seimetz
Ricovr Healthcare Inc.
$645,883
Attributed
$645,883
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $591.5K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$645,883 · 2
By mechanism
R43$645,883 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Commercialization”
- Gary Mays · Axle Informatics, Llc$46,255,260
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Kevin V Grimes · Stanford University$14,783,804
- Heinz Ernst Moser · University Of Texas Med Br Galveston$13,657,841
- Venkata Mangalampalli · Leidos Biomedical Research, Inc.$11,756,555
Research focus
CommercializationFiber OpticsPlasmonicsImmunoassaySalivaMonitorMeasurementNanogoldScreeningUrineTechnologyBiosensorReaderDetectionDevicesLiquid SubstanceImproved OutcomeLiteratureHealthcareHealth PersonnelMarijuana UseDiagnostic TestsDrug Of AbuseClinical Trials
Grant awards (3)
Advancement of a Point-of-Need (PoN) platform device for accurate and destigmatized detection of recent cannabis use$54,382
R43 · FY2025 · DA · contact PI
Quantitative measurement of PlGF using a rapid, low-cost, point-of-care (POC) diagnostic platform for prediction and detection of pre-eclampsia$295,895
R43 · FY2024 · HL · contact PI
Advancement of a Point-of-Need (PoN) platform device for accurate and destigmatized detection of recent cannabis use$295,606
R43 · FY2024 · DA · contact PI